Tumor oxygenation under combined whole-body-hyperthermia and polychemotherapy in a case of recurrent carcinoma of the oral cavity

European Archives of Oto-Rhino-Laryngology

Volumn 259, Issue 1, 2002, Pages 27-31

  Sagowski, C ^a   Jaehne, Michael ^a   Kehrl, Wolfgang ^a   Hegewisch Becker, Susanna ^a   Wenzel, Sören ^a   Panse, Jens ^a   Nierhaus, Axel ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Hyperthermia; Oral cavity; Polychemotherapy; Recurrent squamous cell carcinoma; Tumor oxygenation

Indexed keywords

CARBOPLATIN; IFOSFAMIDE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CARCINOMATOSIS; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; HEAD AND NECK CARCINOMA; HUMAN; HYPERTHERMIC THERAPY; MALE; MOUTH CARCINOMA; OXYGENATION; PREDICTION; PRIORITY JOURNAL; RECTUM TEMPERATURE; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION;

EID: 0036167073     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007524     Document Type: Article

References (27)

1. Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases
2. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study
3. A phase III trial of high-dose paclitaxel + cisplatin + G-CSF versus low-dose paclitaxel + cisplatin in patients with advanced squamous cell carcinoma of the head and neck: An Eastern Cooperative Oncology Group trial
4. Heat shock enhances the susceptibility of tumor cells to lysis by lymphokine activated killer cells
5. Hyperthermic potentiation of cisplatin toxicity in a small lung carcinoma cell line and a cisplatin resistant subline
6. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck
7. Role of tumor necrosis factor α in hyperthermia-induced apoptosis of human leukemia cells
8. Variable efficacy of ifosfamid post-radiation and in untreated primary rhabdomyosarcoma
9. Phase II trial of taxol and cisplatin in advanced squamous cell carcinoma of the head and neck
10. Biweekly paclitaxel and cisplatin in patients with advanced head and neck carcinoma. A phase II study
11. Microvascular and tumor cell alterations during continuous hyperfractioned irradiation: An electron microscopic investigation on the rat R1H rhabdomyosarcoma
12. CD3-large granular lymphocytes recognize a heat-inducible immunogenic determinant associated with the 72-kD heat shock protein on human sarcoma cells
13. A stress-inducible 72-kDa heat shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells
14. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck
15. The effect of whole body hyperthermia on the immune cell activity of cancer patients
16. Phase I clinical trial of melphalan and 41.8°C whole-body hyperthermia in cancer patients
17. 2 in well oxygenated xenotransplanted human sarcoma
18. Reduced oxygenation in a rat mammary carcinoma after chemo- or radiotherapy and reoxygenation with perflubron emulsion/carbogen breathing
19. Oxygenation of human tumors
20. Blood flow in human tumors during local hyperthermia
21. Temperaturabhängigkeit der zytostatikawirkung. Metabolisches milieu und tumoroxygenierung unter hyperthermie
22. Hyperthermia enhances mitoxantrone cytotoxicity on human derived breast carcinoma and sarcoma xenografts in nude mice
23. Hyperthermia enhances cycliphosphamide, ifosfamide and cisdiaminodichloroplatinum (II) cytotoxicity on human derived breast carcinoma and sarcoma xenografts in nude mice
24. Effects of temperature on the therapeutic efficacy and pharmacokinetics of ifosfamide
25. Head and neck cancer
26. Bevölkerungsbezogene krebsregistrierung in Deutschland